Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
To determine the efficacy and safety of surufatinib, toripalimab and chemotherapy in second-line RAS/BRAF mutant and MSS colorectal cancer
创建时间：
2021-02-15
